Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-10-20 |
| Study Made Public: | 2017-09-28 |
Title
Assaying neutralization breadth and potency of recombinantly expressed antibodies isolated from RV305 leukapheresis samples
Description
CAVD 528 is a monoclonal antibody screening study evaluating broadly neutralizing antibodies in select RV305 participants.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.